Takeda Pharmaceutica
4502
End-of-day quote Tokyo - 09/20
4713JPY
+0.58%
Prev.4686.0000
Open4675.0000
High4728.0000
Low4622.0000
Volume5 026 400
Financials
Sales 2019 1 762 B
EBIT 2019 -
R. net 2019 153 B
Debt 2019 680 B
Rend. 2019 3,84%
P/E ratio 2019 22,38
P/E ratio 2020 18,65
EV / Sales 2019 2,50x
EV / Sales 2020 2,35x
Capitalization 3 724 B
Company
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs.It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.The Prescription Drugs segment includes the manufacture...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-09-26 TAKEDA PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
Trading Rating :
Investor Rating :
Latest news
05:29pMOLECULAR TEMPLATES : gains on deal with Takeda
AQ
02:46pMOLECULAR TEMPLATES : Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
AQ
10:28aTAKEDA PHARMACEUTICAL : to move US base to Boston
AQ
09/18TAKEDA PHARMACEUTICAL : receives clearance from the State Administration for Market Regulation in China for the proposed acquisition of Shire plc
AQ
09/18TAKEDA PHARMACEUTICAL : Selected by the Dow Jones Sustainability Asia Pacific Index for the 9th Consecutive Year
PU
09/15TAKEDA PHARMACEUTICAL : Shire gains as takeover approved by China
AQ
09/14SHIRE : Takeda Moving U.S. Headquarters From Chicago Area to Boston
AQ
09/14Takeda gets China's approval for $62 billion Shire purchase
RE
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBearishBearish
Resistance4 7374 9115 349
Spread/Res.-0,51%-4,0%-12%
Spread/Supp.4,2%12%9,9%
Support4 5214 2034 290